Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew K Gould

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Antimicrobial Agents and Chemotherapy|February 20, 2014
Independence from Kinetoplast DNA maintenance and expression is associated with multidrug resistance in Trypanosoma brucei in vitroMatthew K Gould, Achim Schnaufer
FEMS Microbiology Reviews|January 13, 2011
Cyclic-nucleotide signalling in protozoaMatthew K Gould, Harry P de Koning
Proceedings of the National Academy of Sciences of the United States of America|August 21, 2013
Single point mutations in ATP synthase compensate for mitochondrial genome loss in trypanosomesSamuel Dean, Matthew K Gould, Caroline E Dewar, et al.
Analytical Biochemistry|August 30, 2008
Propidium iodide-based methods for monitoring drug action in the kinetoplastidae: comparison with the Alamar Blue assayMatthew K Gould, Xuan Lan Vu, Thomas Seebeck, et al.
European Journal of Medicinal Chemistry|December 17, 2009
Curcuminoid analogs with potent activity against Trypanosoma and Leishmania speciesChatchawan Changtam, Harry P de Koning, Hasan Ibrahim, et al.
Molecular Pharmacology|January 20, 2007
Loss of the high-affinity pentamidine transporter is responsible for high levels of cross-resistance between arsenical and diamidine drugs in African trypanosomesDaniel J Bridges, Matthew K Gould, Barbara Nerima, et al.
Plos Pathogens|July 19, 2018
Mitochondrial DNA is critical for longevity and metabolism of transmission stage Trypanosoma bruceiCaroline E Dewar, Paula MacGregor, Sinclair Cooper, et al.
The Journal of Infectious Diseases|February 1, 2012
Pharmacological validation of Trypanosoma brucei phosphodiesterases as novel drug targetsHarry P de Koning, Matthew K Gould, Geert Jan Sterk, et al.
Nucleic Acids Research|May 21, 2026
A genome-wide genetic screen identifies a novel kDNA replication protein in trypanosomesMigla Miskinyte, Clirim Jetishi, Ana Kalichava, et al.
Plos Neglected Tropical Diseases|August 13, 2016
Reduced Mitochondrial Membrane Potential Is a Late Adaptation of Trypanosoma brucei brucei to Isometamidium Preceded by Mutations in the γ Subunit of the F1Fo-ATPaseAnthonius A Eze, Matthew K Gould, Jane C Munday, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Antimicrobial Agents and Chemotherapy|February 20, 2014
Independence from Kinetoplast DNA maintenance and expression is associated with multidrug resistance in Trypanosoma brucei in vitroMatthew K Gould, Achim Schnaufer
FEMS Microbiology Reviews|January 13, 2011
Cyclic-nucleotide signalling in protozoaMatthew K Gould, Harry P de Koning
Proceedings of the National Academy of Sciences of the United States of America|August 21, 2013
Single point mutations in ATP synthase compensate for mitochondrial genome loss in trypanosomesSamuel Dean, Matthew K Gould, Caroline E Dewar, et al.
Analytical Biochemistry|August 30, 2008
Propidium iodide-based methods for monitoring drug action in the kinetoplastidae: comparison with the Alamar Blue assayMatthew K Gould, Xuan Lan Vu, Thomas Seebeck, et al.
European Journal of Medicinal Chemistry|December 17, 2009
Curcuminoid analogs with potent activity against Trypanosoma and Leishmania speciesChatchawan Changtam, Harry P de Koning, Hasan Ibrahim, et al.
Molecular Pharmacology|January 20, 2007
Loss of the high-affinity pentamidine transporter is responsible for high levels of cross-resistance between arsenical and diamidine drugs in African trypanosomesDaniel J Bridges, Matthew K Gould, Barbara Nerima, et al.
Plos Pathogens|July 19, 2018
Mitochondrial DNA is critical for longevity and metabolism of transmission stage Trypanosoma bruceiCaroline E Dewar, Paula MacGregor, Sinclair Cooper, et al.
The Journal of Infectious Diseases|February 1, 2012
Pharmacological validation of Trypanosoma brucei phosphodiesterases as novel drug targetsHarry P de Koning, Matthew K Gould, Geert Jan Sterk, et al.
Nucleic Acids Research|May 21, 2026
A genome-wide genetic screen identifies a novel kDNA replication protein in trypanosomesMigla Miskinyte, Clirim Jetishi, Ana Kalichava, et al.
Plos Neglected Tropical Diseases|August 13, 2016
Reduced Mitochondrial Membrane Potential Is a Late Adaptation of Trypanosoma brucei brucei to Isometamidium Preceded by Mutations in the γ Subunit of the F1Fo-ATPaseAnthonius A Eze, Matthew K Gould, Jane C Munday, et al.
Pageof 2